Optiwize Inc. Issues Voluntary Recall for OptiWize Collagen Plus Over Ingredient Discrepancy
Optiwize Inc. is recalling 78 bottles of OptiWize Collagen Plus sold nationwide via Amazon after testing showed manganese levels were below the amount listed on the label.
What Happened
Optiwize Inc. has initiated a voluntary recall of its OptiWize Collagen Plus dietary supplement. The recall was prompted after analytical testing conducted by NSF revealed that the quantity of manganese in the product did not align with the levels stated on the label. Specifically, the manganese levels were found to be below the labeled quantity.
Which Products Are Affected
The recall involves 78 units of the following product:
- Product Name: OptiWize Health OptiWize Collagen Plus
- Packaging: 320-count white bottle with a black lid
- Code Information: OHB25230
- Recall Number: H-0442-2026
These products were distributed nationwide across the United States through Amazon distribution channels.
What You Should Do
Consumers who have purchased the affected bottles of OptiWize Collagen Plus should verify the code information on their packaging. As this is a Class III recall—a category used when a product is unlikely to cause adverse health consequences—the primary issue concerns the accuracy of the nutritional labeling. Consumers seeking further information or potential remedies should contact Optiwize Inc. at their Buda, Texas, headquarters.
Why This Matters
This recall is necessary to ensure that consumers receive the specific nutrient levels promised on the product packaging and to maintain the accuracy of dietary supplement labeling standards.
Source
Information provided by the FDA.
Source: FDA Official Notice
Related Articles
Philips North America Recalls Spectral CT 7500 on Rails Over Potential Rotor Part Displacement
FDA · February 25, 2026
Medline Industries Recalls Mercy Circumcision Trays Due to Compromised Packaging
FDA · February 25, 2026
Medline Industries Recalls Reprocessed ViewFlex Xtra ICE Catheters Due to Potential Particle Contamination
FDA · February 25, 2026